Skip to main content

Advertisement

Log in

Increased CSF tau protein in corticobasal degeneration

  • Original communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Using a sensitive sandwich enzyme-linked immunosorbent assay (ELISA) method, we measured the concentration of total tau protein in the cerebrospinal fluid (CSF) from nine patients with corticobasal degeneration (CBD) in comparison with 12 normal control subjects in order to assess its diagnostic value. The CSF concentration of tau in patients with CBD (0.69, 0.20 ng/ml: mean, SD) was higher than that in the normal controls (0.48, 0.14 ng/ml, P = 0.0076 unpaired t test). This increase in CBD patients may reflect widespread tau pathology in CBD, but should be interpreted with reserve as an aid to diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 30 June 1997 Received in revised form: 1 September 1997 Accepted: 7 September 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitani, K., Furiya, Y., Uchihara, T. et al. Increased CSF tau protein in corticobasal degeneration. J Neurol 245, 44–46 (1997). https://doi.org/10.1007/s004150050173

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150050173

Navigation